Stocks in focus, Nov 5: Alembic Pharma, Northern Arc, V2 Retail, Cupid, NALCO, Bright Outdoor, Som Distilleries, Manipal Health
Here are details about stocks that are most likely to see significant action today
Alembic Pharmaceuticals has expanded its collaboration with DifGen Pharmaceuticals, leveraging DifGen's US manufacturing capabilities and Alembic's US commercial platform. Northern Arc Investment Managers has launched its 15th private credit fund, the Northern Arc Diversified Debt Fund, with commitments exceeding ₹400 crore. V2 Retail has entered a strategic retail arrangement with Cupid Limited, securing dedicated retail space across V2 Retail's stores.
NALCO is expanding its smelting capacity at Anugola, Odisha, by 0.5 MTPA through a ₹30,000 crore brownfield project. Bright Outdoor Media is set to list on the BSE Main Board following approval for migration from the BSE SME Platform. SOM Distilleries has renewed its contract manufacturing agreement with Carlsberg India for three more years.
TIL Investments Pvt Ltd has leased land to Manipal Health Enterprises for a multi-specialty hospital in Gurugram.
Written by urgent.news from Hindu BusinessLine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
